TL;DR
This study reveals that elevated serum uric acid (SUA) levels are a significant risk factor for developing multiterritorial atherosclerosis, meaning blockages in multiple arteries across the body. The findings highlight that higher SUA is linked to a greater likelihood of developing vascular stenosis, particularly in men for intracranial artery stenosis.
What Problem Does This Paper Address?
Cardiovascular diseases remain a leading cause of death globally, and atherosclerosis – the buildup of plaque in arteries – is a primary driver. When atherosclerosis affects multiple arterial territories (e.g., brain, neck, and legs), the risk of adverse cardiovascular events like heart attacks and strokes dramatically increases. While serum uric acid (SUA) has been implicated as a risk factor for atherosclerosis, much of the existing evidence comes from cross-sectional studies, which can't establish cause and effect. There's a need for robust, longitudinal data to confirm if elevated SUA truly predicts the development of widespread atherosclerosis. This paper aims to fill that gap by investigating the longitudinal association between SUA levels and the development of asymptomatic, multiterritorial vascular stenosis in a community-based cohort.
Methods
The researchers conducted a prospective cohort study, the Asymptomatic Polyvascular Atherosclerosis Community (APAC) study, involving 2644 North Chinese adults aged 40 and older. Participants underwent two assessments, approximately two years apart.
Key methods included:
- Vascular Stenosis Assessment:
- Intracranial Artery Stenosis (ICAS): Assessed using transcranial Doppler (TCD) by measuring peak systolic flow velocity in specific cerebral arteries.
- Extracranial Arterial Stenosis (ECAS): Evaluated using bilateral carotid duplex ultrasound to identify stenosis in the common or internal carotid arteries and vertebral arteries.
- Peripheral Arterial Disease (PAD): Determined by the ankle-brachial index (ABI), a ratio of ankle to brachial systolic blood pressure.
- Serum Uric Acid (SUA) Measurement: Blood samples were collected and analyzed to determine SUA levels. Hyperuricaemia was defined as SUA levels >7.0 mg/dL for males and >6.0 mg/dL for females.
- Statistical Analysis: Multivariable logistic regression was employed to assess the association between SUA levels (both hyperuricaemia and per 1 mg/dL increase) and the onset of new vascular stenosis, adjusting for a comprehensive set of covariates (age, sex, BMI, education, income, smoking, alcohol consumption, physical activity, hypertension, diabetes mellitus, hyperlipidaemia, CRP, ALB, and eGFR). Restricted cubic spline (RCS) models were used to explore non-linear relationships. Gender-stratified analyses were also performed.
Datasets
The study utilized data from the APAC (Asymptomatic Polyvascular Atherosclerosis Community) cohort study. This was a prospective, community-based cohort of 2644 North Chinese adults aged 40 and older, with baseline data collected between 2010-2012 and a follow-up assessment two years later. No new benchmarks were introduced; the study focused on analyzing existing clinical data.
Key Insights and Ideas
- SUA as a Predictor of Widespread Atherosclerosis: The study provides strong longitudinal evidence that elevated SUA is not just associated with atherosclerosis in one area, but significantly increases the risk of developing blockages across multiple arterial systems. This is a crucial finding for understanding the systemic nature of SUA's impact.
- Gender Differences in ICAS: The association between high SUA and intracranial artery stenosis (ICAS) was significant in men but not in women. This suggests that the mechanisms linking SUA to brain artery blockages might differ between sexes, potentially due to hormonal influences or other biological factors.
- Threshold Effect for ICAS: The analysis hinted at a potential "threshold effect" for SUA on ICAS, where the risk only becomes significant above a certain SUA level, and this threshold might be reached more frequently in men.
- ECAS is Consistently Linked to SUA: Unlike ICAS, the association between elevated SUA and extracranial arterial stenosis (ECAS) was robust across both genders, reinforcing SUA's role in this specific type of vascular disease.
Key Results
- Higher Incidence of Stenosis in Hyperuricaemic Individuals: Participants with hyperuricaemia had a significantly higher cumulative incidence of vascular stenosis (54.1%) compared to those without hyperuricaemia (34.7%) over the two-year follow-up period (P < 0.001).
- Increased Risk of Vascular Stenosis:
- Hyperuricaemia was associated with a 1.75-fold increased risk of new-onset vascular stenosis (95% CI: 1.32-2.31) after full adjustment.
- Each 1-mg/dL increase in SUA level was associated with a 1.29-fold increased risk of new-onset vascular stenosis (95% CI: 1.21-1.38).
- Gender-Specific ICAS Risk: For ICAS, the adjusted odds ratio for hyperuricaemia was 2.02 (95% CI: 1.18-3.46) in males, but not statistically significant in females (OR: 0.85, 95% CI: 0.41-1.76), with a significant P for interaction (0.026).
- Consistent ECAS Risk: The adjusted odds ratio for hyperuricaemia was 2.17 (95% CI: 1.61-2.94) for ECAS, showing a significant association in both genders.
Limitations and Future Work
The authors acknowledge several limitations:
- Focus on Asymptomatic Stenosis: The study evaluated asymptomatic ICAS and ECAS. Causes of stenosis other than atherosclerosis (e.g., vasculitis) were not assessed.
- Limited PAD Events: The analysis of PAD was limited due to a low number of events.
- Medication Effects: The potential attenuation of vascular stenosis risk by drugs that lower serum uric acid was not fully accounted for, as data on such treatments were unavailable.
- TCD Operator Dependence: ICAS diagnosis via TCD is partly operator-dependent and may not precisely determine the extent of stenosis.
Future work could explore the specific mechanisms linking SUA to atherosclerosis, particularly the gender-specific differences observed in ICAS. Further research into the impact of SUA-lowering therapies on the progression of multiterritorial atherosclerosis would also be valuable. The study also suggests that there might be a threshold effect for SUA on ICAS, warranting further investigation into this phenomenon.
Summary updated